Search

Author/Creator Su, Chinyu

13. Impact of Baseline Corticosteroid Therapy on Tofacitinib Induction Efficacy and Infection Risk in Patients With Ulcerative Colitis: Data From Global Clinical Trials: 706. (October 2019)

Authors:
Lichtenstein, Gary R.; Cohen, Benjamin L.; Salese, Leonardo; Soonasra, Arif; Modesto, Irene; Wang, Wenjin; Woodworth, Deborah A.; Chan, Gary; Quirk, Daniel; Su, Chinyu; Peyrin‐Biroulet, Laurent
Journal:
American journal of gastroenterology
Issue:
Volume 114 (2019)ACG Abstracts 1:Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Incidence of Venous Thromboembolic Events in Patients With Ulcerative Colitis Treated With Tofacitinib in the Ulcerative Colitis Clinical Development Program: 644. (October 2019)

Authors:
Sandborn, William J.; Panés, Julian; Sands, Bruce E.; Reinisch, Walter; Su, Chinyu; Lawendy, Nervin; Koram, Nana; Fan, Haiyun; Jones, Thomas V.; Modesto, Irene; Quirk, Daniel; Danese, Silvio
Journal:
American journal of gastroenterology
Issue:
Volume 114 (2019)ACG Abstracts 1:Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Integrated Safety Analyses of Tofacitinib in Ulcerative Colitis Clinical Trials: 731. (October 2017)

Authors:
Sandborn, William J.; Panés, Julian; D'Haens, Geert; Sands, Bruce E.; Su, Chinyu; Moscariello, Michele; Jones, Thomas V.; Pedersen, Ronald D.; Friedman, Gary S.; Lawendy, Nervin; Chan, Gary
Journal:
American journal of gastroenterology
Issue:
Volume 112(2017)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply. Issue 10 (27th April 2020)

Authors:
Sands, Bruce E.; Armuzzi, Alessandro; Marshall, John K.; Lindsay, James O.; Sandborn, William J.; Danese, Silvio; Panés, Julián; Bressler, Brian; Colombel, Jean‐Frédéric; Lawendy, Nervin; Maller, Eric; Zhang, Haiying; Chan, Gary; Salese, Leonardo; Tsilkos, Konstantinos; Marren, Amy; Su, Chinyu
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 51:Issue 10(2020)
Page Start:
997
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis—two cases in real world clinical practice. Authors' reply. Issue 11 (19th May 2020)

Authors:
Sandborn, William J.; Panés, Julian; Sands, Bruce E.; Reinisch, Walter; Su, Chinyu; Lawendy, Nervin; Koram, Nana; Fan, Haiyun; Jones, Thomas V.; Modesto, Irene; Quirk, Daniel; Danese, Silvio
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 51:Issue 11(2020)
Page Start:
1209
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management. Issue 6 (17th May 2021)

Authors:
Sands, Bruce E; Colombel, Jean-Frédéric; Ha, Christina; Farnier, Michel; Armuzzi, Alessandro; Quirk, Daniel; Friedman, Gary S; Kwok, Kenneth; Salese, Leonardo; Su, Chinyu; Taub, Pam R
Journal:
Inflammatory bowel diseases
Issue:
Volume 27:Issue 6(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19. Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management. Issue 6 (1st September 2020)

Authors:
Sands, Bruce E; Colombel, Jean-Frédéric; Ha, Christina; Farnier, Michel; Armuzzi, Alessandro; Quirk, Daniel; Friedman, Gary S; Kwok, Kenneth; Salese, Leonardo; Su, Chinyu; Taub, Pam R
Journal:
Inflammatory bowel diseases
Issue:
Volume 27:Issue 6(2021)
Page Start:
797
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

20. Long‐term safety and tolerability of oral tofacitinib in patients with Crohn's disease: results from a phase 2, open‐label, 48‐week extension study. Issue 3 (20th January 2019)

Authors:
Panés, Julián; D'Haens, Geert R.; Higgins, Peter D. R.; Mele, Linda; Moscariello, Michele; Chan, Gary; Wang, Wenjin; Niezychowski, Wojciech; Su, Chinyu; Maller, Eric
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 49:Issue 3(2019)
Page Start:
265
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗